Avicanna Inc. (AVCN) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Avicanna Inc.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04265-cf8f-7202-80b4-5591ef92077f Created: 2026-08-27T08:46:05.407Z Duration: 2226.9387 Channels: 1 00:00:01.040 -- 00:00:03.520 All right. We'll get started. Thank you for 00:00:03.520 -- 00:00:06.640 joining everyone. My name is Arat Azadian, CEO 00:00:06.640 -- 00:00:08.160 and Founder of Avicanna. 00:00:08.320 -- 00:00:10.240 Some of you would know me for a 00:00:10.240 -- 00:00:11.679 long time. This is my tenth year in 00:00:11.679 -- 00:00:12.320 the role. 00:00:12.960 -- 00:00:14.400 Joined today by with 00:00:15.035 -- 00:00:17.275 Doctor. Caroline Irvin, who is our EVP of 00:00:17.275 -- 00:00:19.435 Scientific Affairs and Medical Affairs 00:00:19.675 -- 00:00:22.395 and Nick Auburn, who is our Interim CFO. 00:00:22.795 -- 00:00:24.475 We're going to take you over some of 00:00:24.475 -- 00:00:27.115 the corporate updates from 2025, 00:00:27.435 -- 00:00:28.955 then a little bit of an overview of 00:00:28.955 -- 00:00:31.010 where we stand as a corporation. But of 00:00:31.010 -- 00:00:33.330 course, I look forward as well into 2026 00:00:33.330 -- 00:00:36.210 and what's coming, which is very exciting. In 00:00:36.210 -- 00:00:37.490 addition to that, we're going to leave a 00:00:37.490 -- 00:00:38.850 little bit of time for Q and A 00:00:38.850 -- 00:00:40.130 at the end. 00:00:42.290 -- 00:00:44.130 So customary disclaimer notice, 00:00:44.995 -- 00:00:46.754 But for some of you that are new 00:00:46.754 -- 00:00:48.835 to the company, I'll spend a minute or 00:00:48.835 -- 00:00:51.235 two on just who we are. So Avicanna 00:00:51.235 -- 00:00:54.835 is now a fully vertically integrated cannabinoid based 00:00:54.835 -- 00:00:55.954 pharma company. 00:00:56.195 -- 00:00:58.289 We have establis...